Fangyuan Capital (Hong Kong) Limited
Overview
Fangyuan Capital (Hong Kong) Limited is a private equity investment firm focused on the life sciences and healthcare sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Innorna | Mar 2022 | Series B | Co-investor |
| HebeCell | Aug 2021 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Fangyuan Capital (Hong Kong) Limited based?
Fangyuan Capital (Hong Kong) Limited is headquartered in Hong Kong, Hong Kong.
When was Fangyuan Capital (Hong Kong) Limited founded?
Fangyuan Capital (Hong Kong) Limited was founded in 2017.
How many portfolio companies does Fangyuan Capital (Hong Kong) Limited have?
Fangyuan Capital (Hong Kong) Limited has 4 portfolio companies in Caplight's dataset.
What are some companies in Fangyuan Capital (Hong Kong) Limited's portfolio?
Portfolio companies visible on Caplight include Innorna, HebeCell.
What was Fangyuan Capital (Hong Kong) Limited's most recent investment shown here?
Fangyuan Capital (Hong Kong) Limited's most recent investment in this portfolio sample was in Innorna in 2022.
What sectors does Fangyuan Capital (Hong Kong) Limited focus on?
Fangyuan Capital (Hong Kong) Limited focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Fangyuan Capital (Hong Kong) Limited focus on?
Fangyuan Capital (Hong Kong) Limited typically invests at the Early stage.